Yoshiyuki Ohno

Twitter (United States) — United States

Medicine · Health Sciences

52h-index8.5kcitations266works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Risks and Factors(18), Nutritional Studies and Diet(17), Global Cancer Incidence and Screening(16), Pharmacogenetics and Drug Metabolism(15), Bladder and Urothelial Cancer Treatments(14)

Publications266 total

Impact of Physician Storytelling and Peer-to-Peer Conversation on Medical Students’ Coping Skills and Anticipatory Fear Surrounding Patient Death: A Pre-post Cohort Study
Cureus·2025Open Access
Advancing Drug Interaction Management Based on the Pharmacokinetic Drug Interaction Significance Classification System (PISCS)
YAKUGAKU ZASSHI·2025Open Access
Assessment of the Potential Risk of Cytochrome P450-Mediated Drug–Drug Interactions in Psychiatric Inpatients
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)·2025Open Access
The Intersection of Disability, Race, Ethnicity, and Financial Background on Food Insecurity Among Medical Students
Academic Medicine·2025· 3 cited
Prediction of methotrexate neurotoxicity using clinical, sociodemographic, and area-based information in children with acute lymphoblastic leukemia
The Oncologist·2025Open Access
Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy·2024· 2 citedOpen Access
A case of gas gangrene caused by <i>Clostridium septicum</i> with undiagnosed advanced colon cancer
The Journal of Dermatology·2024Open Access
Induction of CYP3A activity by dexamethasone may not be strong, even at high doses: insights from a case of tacrolimus co-administration
Journal of Pharmaceutical Health Care and Sciences·2023· 3 citedOpen Access
The Incidence of Heterotopic Ossification in Surgically and Non-surgically Treated Elbow Fractures at a Municipal Hospital in Japan
The Journal of Hand Surgery (Asian-Pacific Volume)·2023· 2 cited
LBA63 Placebo-controlled, double-blinded phase Ⅲ study comparing dexamethasone on day 1 with dexamethasone on days 1 to 4, with combined neurokinin-1 receptor antagonist, palonosetron, and olanzapine in patients receiving cisplatin-containing highly emetogenic chemotherapy: SPARED trial
Annals of Oncology·2021· 4 cited
Classification of drugs for evaluating drug interaction in drug development and clinical management
Drug Metabolism and Pharmacokinetics·2021· 37 citedOpen Access
Corrigendum to “The JAPAN-FORTA (Fit fOR The Aged) list: Consensus validation of a clinical tool to improve drug therapy in older adults” [Archives of Gerontology and Geriatrics 91 (November–December) (2020) 104217]
Archives of Gerontology and Geriatrics·2020Open Access
The JAPAN-FORTA (Fit fOR The Aged) list: Consensus validation of a clinical tool to improve drug therapy in older adults
Archives of Gerontology and Geriatrics·2020· 21 cited
Dual EGFR and ABL Tyrosine Kinase Inhibitor Treatment in a Patient with Concomitant EGFR-Mutated Lung Adenocarcinoma and BCR-ABL1-Positive CML
Case Reports in Oncological Medicine·2020· 5 citedOpen Access
Prophylactic effect of rikkunshito, an herbal medicine, for chemotherapy-induced nausea in thoracic cancer patients receiving carboplatin-based chemotherapy.
PubMed·2019· 5 cited
Prevalence of cytochrome P450‐mediated potential drug–drug interactions in residents of intermediate care facilities for older adults in Japan
Geriatrics and gerontology international/Geriatrics & gerontology international·2019· 8 cited
How to Manage Drug Interactions in Clinical Settings (2)
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)·2018Open Access
How to Manage Drug Interactions in Clinical Settings (1)
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)·2018· 3 citedOpen Access
How to Manage Drug Interactions in Clinical Settings (3)
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)·2018Open Access
Quantitative Prediction of Drug-Drug Interaction Caused by CYP Inhibition and Induction from &lt;i&gt;In Vivo&lt;/i&gt; Data and Its Application in Daily Clinical Practices—Proposal for the Pharmacokinetic Interaction Significance Classification System (PISCS)
YAKUGAKU ZASSHI·2018· 4 citedOpen Access
page 1 of 14Next →

Frequent Co-authors

Akiko Tamakoshi(28), Kenji Wakai(18), Takashi Kawamura(18), Yingsong Lin(13), Yutaka Inaba(9), Rie Aoki(8), Masayo Kojima(7), Shogo Kikuchi(6), Takaaki Kondo(6), Toshiko Nakayama(6), Yoshiyuki Watanabe(4), Kunio Aoki(4), Tetsuo Hayakawa(4), Koji Suzuki(4), Nao Seki(4), Yoshikazu Nishino(4), Masahiko Ando(4), Hideaki Toyoshima(3), Keiichiro Genka(3), Toshiro Takezaki(3)